BioNexus Gene Lab Corp (NASDAQ: BGLC) Stock Information | RedChip

BioNexus Gene Lab Corp (NASDAQ: BGLC)


$0.52
-0.0104 ( -1.96% ) 31.4K

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Market Data


Open


$0.52

Previous close


$0.53

Volume


31.4K

Market cap


$9.36M

Day range


$0.48 - $0.53

52 week range


$0.31 - $16.20

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 1 Oct 04, 2023
3 Insider transactions 1 Oct 04, 2023
8-k 8K-related 14 Sep 07, 2023
10-q Quarterly Reports 64 Aug 16, 2023
nt Quarterly Reports 1 Aug 14, 2023
8-k 8K-related 22 Jul 24, 2023
8-k 8K-related 20 Jul 20, 2023

Latest News